You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Brodalumab for treating moderate to severe plaque psoriasis

  • Technology appraisal guidance
  • Reference number: TA511
  • Published:  21 March 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 240 KB)

    Published:
    21 March 2018

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 362 KB)

    Published:
    09 February 2017
  • Committee papers (PDF 10.52 MB)

    Published:
    09 February 2017
  • Public committee slides (PDF 888 KB)

    Published:
    09 February 2017

Invitation to participate

  • Final scope (PDF 252 KB)

    Published:
    05 September 2017
  • Final matrix (PDF 255 KB)

    Published:
    05 September 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 496 KB)

    Published:
    05 September 2017
  • Equality impact assessment (Scoping) (PDF 173 KB)

    Published:
    05 September 2017
Back to top